ETRACS 2x Leveraged US Growth Factor TR ETN
IWFL
0 hedge funds and large institutions have $0 invested in ETRACS 2x Leveraged US Growth Factor TR ETN in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
3.72% less ownership
Funds ownership: 3.72% → 0% (-3.7%)
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $533K → $0 (-$533K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IMC Chicago
Chicago,
Illinois
|
-$533K |
IWFL Hedge Fund Activity: Q3 2025 in Review
0 of the 7,622 institutional investors tracked by Wall St. Rank reported a position in ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) for Q3 2025, worth a combined $0 — down 100% from $533K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of IWFL and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was IMC Chicago, exiting entirely with an estimated $533K sold.
- 0 institutional investors held ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) as of Q3 2025, down from 1 in Q2 2025.
- Funds reported $0 of ETRACS 2x Leveraged US Growth Factor TR ETN stock for Q3 2025, down 100% quarter-over-quarter.
- 0 funds opened new ETRACS 2x Leveraged US Growth Factor TR ETN positions in Q3 2025 and 1 closed out, a net change of -1 holder.
- The largest ETRACS 2x Leveraged US Growth Factor TR ETN seller in Q3 2025 was IMC Chicago, an estimated $533K sold.
Based on aggregated 13F filings for Q3 2025.